Doctor shopping is the behavior most people picture when they imagine prescription drug misuse: someone visiting multiple physicians, collecting overlapping prescriptions, filling them at different pharmacies. For years, it was the signature warning sign families were told to watch for.
The landscape has changed considerably, and the change cuts both ways. The behavior has become much harder to sustain, which is good. It has also become a less reliable signal than it used to be, and the systems designed to catch it now flag a meaningful number of people who are sick. Knowing both halves of that helps families read what they are actually seeing.
Key Takeaways
- Doctor shopping means obtaining overlapping prescriptions from multiple prescribers, often filled at multiple pharmacies.
- A standard research definition is five or more prescribers and five or more pharmacies within 90 days.
- Rates fell roughly 73% between 2010 and 2017 as prescription monitoring programs became widespread.
- By 2017, nearly one-fifth of people flagged by the standard algorithm had documented cancer diagnoses.
- Because the classic pattern has declined, families should watch behavior rather than waiting for this specific sign.
What the Term Actually Means
In research and monitoring contexts, doctor shopping describes what analysts call multiple provider episodes: a threshold count of distinct prescribers or pharmacies involved in filling prescriptions. The underlying behavior is obtaining overlapping prescriptions from several prescribers for the same drug, which yields higher total doses than any single prescriber is authorized to provide.
Definitions vary. The most commonly used research standard identifies patients receiving opioid prescriptions from five or more prescribers and five or more pharmacies within a 90-day window. Others use six or more prescriptions from six or more prescribers within six months.
Those thresholds exist because occasional overlap is normal. A patient who sees a primary care physician, has a surgery, visits urgent care once, and fills at two pharmacies is not doing anything wrong. The pattern only becomes meaningful at volume.
Why the Signal Has Faded
This is the part families are rarely told, and it changes how much weight to put on this particular sign.
A study examining doctor and pharmacy shopping as a signal for prescription opioid monitoring documented a sharp decline. Multiple provider episode rates fell by roughly 73% between 2010 and 2017, dropping from 18.2 to 4.9 per 100,000 enrollees with controlled substance prescriptions.
The reason is straightforward. Prescription drug monitoring programs became universal across states, and they let a prescriber or pharmacist check a patient’s controlled substance history before prescribing or filling a prescription. That made the old approach very difficult to sustain, which is exactly what the programs were designed to do.
The same study raised a concern worth taking seriously. By 2017, nearly one-fifth of the people flagged by the standard algorithm had documented cancer diagnoses. In other words, a substantial share of those the system identified were patients with complex medical needs and high healthcare utilization rather than people misusing medication. The authors concluded that more nuanced approaches are needed to avoid misidentifying legitimate patients while maintaining vigilance.
For a family, the practical implication is that seeing several prescribers is weak evidence on its own, and its absence proves nothing either. Someone with a serious substance use problem today is more likely to have moved to illicit sources than to be assembling prescriptions.
Seven Signs Worth Watching
Behavior remains more informative than prescription counts. These are the patterns that tend to matter.
- Running out early, repeatedly. A prescription written for 30 days that is gone in 18, more than once, indicates use above what was prescribed.
- Lost or stolen prescriptions. It happens legitimately. It happens repeatedly far less often.
- Appointments in unusual places or at unusual times. Urgent care visits on weekends and holidays, or clinics far from home, when a regular physician exists.
- Defensiveness about medication. Reactions disproportionate to the question when anyone asks about a prescription.
- Pills in unlabeled containers, or medication kept in unusual places rather than where household medications live.
- Escalating complaints without a matching change in condition. Pain descriptions that intensify while the underlying diagnosis is stable.
- Withdrawal symptoms between refills, including sweating, irritability, nausea, restlessness, and poor sleep that resolve after a refill.
The last of those is the most diagnostic and the most frequently missed. Symptoms that appear on a schedule matching the prescription cycle and disappear when the prescription is refilled describe physical dependence regardless of how the medication is being obtained.
Broader behavioral changes matter as much: withdrawal from relationships, declining performance at work, financial irregularities, and mood changes that track with medication access. Those overlap heavily with the early signs that a loved one needs treatment, which is the more useful frame than watching for one specific behavior.
How to Raise It
The conversation goes better with preparation than with confrontation, and the goal is engagement rather than admission.
- Choose a calm, private moment, not one immediately after an incident and not when the person is impaired.
- Lead with specific observations. “The prescription from the 3rd was gone by the 12th” is harder to deflect than “I think you have a problem.”
- Speak to concern rather than accusation. The aim is a door left open, not a case proven.
- Expect denial and do not treat it as the end. First conversations rarely produce agreement, and they frequently matter anyway.
- Have an option ready. A specific number to call or appointment available is worth more than a general suggestion.
- Do not remove medication abruptly. Withdrawal from opioids, benzodiazepines, or other prescribed drugs can be dangerous and sometimes life-threatening.
That final point deserves emphasis. Families sometimes respond by confiscating medication, which is understandable and can be genuinely dangerous. Benzodiazepine withdrawal in particular can cause seizures. Any reduction belongs with a clinician.
Where individual conversations have not worked, a structured approach with professional guidance is the next step, and how families can stage an effective intervention covers what that involves. The difference between a productive intervention and a damaging one is almost entirely preparation.
Working With Prescribers
Families often want to call a physician, and it is worth understanding what that can and cannot accomplish.
A prescriber generally cannot discuss a patient’s care with you without authorization. What they can do is receive information. A family member may share concerns even where the physician cannot respond, and that information can inform care.
Prescribers also have tools families do not. Every state operates a prescription drug monitoring program showing controlled substance fills across prescribers and pharmacies, and prescribers can check it. Concerns raised by family can prompt that review.
Using a single pharmacy is another practical step, since the pharmacist then sees the complete picture and is positioned to catch interactions and overlaps that scattered filling hides.
It helps to understand what those programs actually are. A clinical reference on prescription drug monitoring programs describes them as state-run databases that track controlled-substance dispensing, which prescribers and pharmacists query before writing or filling. Some states send unsolicited reports to clinicians when a patient’s pattern crosses a threshold, rather than waiting for someone to check.
They are not perfect instruments. Analysis of the limitations of prescription drug monitoring programs notes gaps including delays between dispensing and data appearing, incomplete interstate sharing, and variation in whether checking is mandatory. A person determined to work around one can, particularly across state lines, though it is far harder than it was.
Earlier prevalence work estimating opioid diversion by doctor shoppers found that a small number of individuals accounted for a disproportionate share of diverted supply, which is part of why the monitoring approach was built around identifying extreme outliers rather than moderate ones.
What Happens Next
Where dependence has developed, stopping is not simply a matter of resolve, and the medical piece needs to be handled first.
Opioid dependence responds well to medication-assisted treatment, and outcomes are substantially better with medication than without. Benzodiazepine and sedative dependence requires a gradual supervised taper rather than abrupt cessation. Stimulant dependence has no approved medication and is treated behaviorally.
Underneath the prescription question, there is usually a treatable condition that was being managed. Pain, anxiety, or insomnia that led to the original prescription does not disappear when the medication does, and a plan that removes the medication without addressing what it was doing tends not to hold. That is the same pattern seen with high-functioning alcohol use, where the outward picture stays intact for a long time, and the underlying driver goes unaddressed.
The reason to act on suspicion rather than wait for proof is that the classic evidence people wait for has largely stopped appearing. Prescription monitoring made assembling prescriptions difficult, and the people who would once have done that have generally moved on to a supply that is considerably more dangerous. Waiting for a pattern that the system has mostly eliminated means waiting through the period when intervening would have been easiest.
References
- Doctor Shopping Laws – Centers for Disease Control and Prevention
- Doctor and Pharmacy Shopping: A Fading Signal for Prescription Opioid Use Monitoring? – National Library of Medicine
- Prescription Drug Monitoring Program – StatPearls, National Center for Biotechnology Information
- Prescription Drug Monitoring Programs: Examining Limitations and Future Approaches – National Library of Medicine
- Estimating the Prevalence of Opioid Diversion by Doctor Shoppers in the United States – National Library of Medicine
FAQs
How Many Doctors Count as Doctor Shopping?
Research commonly uses five or more prescribers and five or more pharmacies within 90 days, or six or more prescriptions from six or more prescribers within six months. Occasional overlap from surgery, urgent care, or specialist visits is normal and is not what these thresholds are designed to catch.
Is Doctor Shopping Still Common?
Much less than it was. Multiple provider episode rates fell roughly 73% between 2010 and 2017 as prescription drug monitoring programs became widespread. That is a genuine success, and it means the absence of this pattern no longer rules out a problem.
Can I Call My Family Member’s Doctor?
You generally cannot receive information without authorization, and you can provide it. Sharing specific observations with a prescriber is worthwhile even when they cannot respond, since it can prompt them to review the state monitoring database.
Should I Take Away Their Medication?
No. Abrupt discontinuation of opioids, benzodiazepines, or other prescribed medications can cause dangerous withdrawal, and benzodiazepine withdrawal can cause seizures. Any reduction should be managed by a clinician rather than imposed at home.
What if They Have a Legitimate Medical Need?
Many people do, and the monitoring systems themselves struggle with this. By 2017, nearly one-fifth of those flagged by the standard algorithm had documented cancer diagnoses. Legitimate need and problematic use can also coexist, which is a clinical question rather than one a family should try to settle alone.
